TrademarkDir
TYVASO DPI (TREPROSTINIL) INHALATION POWDER
LIVE

Serial Number

90370409

Owner

United Therapeutics Corporation

Attorney

Norm J. Rich

First Use Date

Oct 28, 2020

Filing Date

Dec 9, 2020

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TYVASO DPI (TREPROSTINIL) INHALATION POWDER Trademark

Serial Number: 90370409 • Registration: 6756715

TYVASO DPI (TREPROSTINIL) INHALATION POWDER is a trademark filed by United Therapeutics Corporation on December 9, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

United Therapeutics Corporation (85 trademarks)

1110 Spring Street
Silver Spring, MD 20910

Entity Type: 03

Trademark Details

Filing Date

December 9, 2020

Registration Date

June 14, 2022

First Use Anywhere

October 28, 2020

First Use in Commerce

October 28, 2020

Published for Opposition

March 29, 2022

Goods & Services

Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension and interstitial lung disease, and idiopathic pulmonary fibrosis, where the pharmaceutical preparations contain prostaglandins

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 14, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 29, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 29, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 9, 2022 NONP
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Feb 18, 2022 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2022 CNSA
USE AMENDMENT ACCEPTED
Feb 17, 2022 IUAA
EXAMINER'S AMENDMENT ENTERED
Feb 16, 2022 XAEC
ASSIGNED TO LIE
Feb 16, 2022 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 15, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 15, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 15, 2022 CNEA
AMENDMENT TO USE PROCESSING COMPLETE
Nov 30, 2021 AUPC
USE AMENDMENT FILED
Nov 30, 2021 IUAF
TEAS AMENDMENT OF USE RECEIVED
Nov 29, 2021 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 18, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 10, 2021 GNRN
NON-FINAL ACTION E-MAILED
Jun 10, 2021 GNRT
NON-FINAL ACTION WRITTEN
Jun 10, 2021 CNRT
ASSIGNED TO EXAMINER
May 28, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Feb 17, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2021 NWOS
NEW APPLICATION ENTERED
Dec 12, 2020 NWAP

Related Trademarks

More from this Owner

TYVASO SMI-PF

TYVASO SMI-PF

UNITED THERAPEUTICS PHARMACY SERVICES

UNITED THERAPEUTICS PHARMACY SERVICES

UNITED THERAPEUTICS PHARMACY SERVICES

UNITED THERAPEUTICS PHARMACY SERVICES

RALDPI

RALDPI

TRESMI

TRESMI

RALSMI

RALSMI